These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39202232)

  • 1. Performance Evaluation of Open Channel Buhlmann Fecal Calprotectin Turbo Assay on Abbott Alinity C Analyzer.
    Sataranatarajan K; Adhikari S; Nguyen N; Narasimhan M; Balani J; Muthukumar A
    Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.
    Garnett E; Pagaduan J; Rajapakshe D; Tam E; Kellermayer R; Devaraj S
    Pract Lab Med; 2020 Nov; 22():e00178. PubMed ID: 33134465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of the Bühlmann fCAL turbo faecal calprotectin assay on the Binding Site Optilite benchtop analyser.
    Handley SA; Dote NP; Wanandy T; Prentice L
    Pract Lab Med; 2023 Aug; 36():e00318. PubMed ID: 37649548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis.
    Hejl J; Theede K; Møllgren B; Madsen KV; Heidari A; Á Steig A; Fenger M
    Pract Lab Med; 2018 Mar; 10():10-14. PubMed ID: 29234707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.
    Mandic-Havelka A; Nilsen T; Sunde K; Norell M; Hansson LO; Larsson A
    Clin Lab; 2017 May; 63(5):907-913. PubMed ID: 28627817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
    Noebauer B; Ramic L; Konstantin A; Zachbauer C; Einwallner E
    Biochem Med (Zagreb); 2017 Oct; 27(3):030710. PubMed ID: 29180918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease.
    Oka A; Kawashima K; Kishimoto K; Kotani S; Fukunaga M; Fukuba N; Mishima Y; Oshima N; Ishimura N; Awoniyi M; Ishihara S
    Sci Rep; 2024 Jan; 14(1):1653. PubMed ID: 38238442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the fCAL turbo immunoturbidimetric assay for measurement of calprotectin in porcine and bovine fecal samples.
    Pato R; Peña R; Pelegrí-Pineda A; Crusellas-Villorbina N; Pisoni L; Devant M; Marti S; Solà-Oriol D; Bassols A; Saco Y
    Res Vet Sci; 2023 Nov; 164():105042. PubMed ID: 37806097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample comparison of BÜHLMANN fCAL Turbo and OC-FCa faecal calprotectin methods.
    O'Driscoll S; Piggott C; Benton SC
    Ann Clin Biochem; 2024 Aug; ():45632241273266. PubMed ID: 39093620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers.
    Nilsen T; Sunde K; Hansson LO; Havelka AM; Larsson A
    J Clin Lab Anal; 2017 Jul; 31(4):. PubMed ID: 27629827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay.
    Lin L; Wyness SP; Jensen R; Bird J; Norgyal T; Jensen G; Johnson LM
    Am J Clin Pathol; 2022 Feb; 157(2):252-256. PubMed ID: 34390332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
    De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
    Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verification of the fCAL turbo immunoturbidimetric assay for measurement of the fecal calprotectin concentration in dogs and cats.
    Enderle LL; Köller G; Heilmann RM
    J Vet Diagn Invest; 2022 Sep; 34(5):813-824. PubMed ID: 35879875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a fluorescent immunochromatography test for fecal calprotectin.
    Li R; Zhao X; Dong J; Zhu D; Wang T; Yang S; Zhao Z; Xiao N
    J Clin Lab Anal; 2020 Feb; 34(2):e23059. PubMed ID: 31587371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies.
    Riggers DS; Xenoulis PG; Karra DA; Enderle LL; Köller G; Böttcher D; Steiner JM; Heilmann RM
    Vet Sci; 2023 Jun; 10(7):. PubMed ID: 37505825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease.
    El-Matary W; Abej E; Deora V; Singh H; Bernstein CN
    Front Pediatr; 2017; 5():7. PubMed ID: 28180127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of the Bühlmann fPELA turbo faecal elastase assay on the Binding Site Optilite benchtop analyser.
    Handley SA; Dote NP; Wanandy T; Prentice L
    Ann Clin Biochem; 2023 Jan; 60(1):68-71. PubMed ID: 36286495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference Intervals for Fecal Calprotectin in Adults Using Two Different Extraction Methods in the Uppsala-SCAPIS Cohort.
    Fall T; Mandic-Havelka A; Helmersson-Karlqvist J; Sundstrom J; Larsson A
    Clin Lab; 2017 Sep; 63(9):1493-1496. PubMed ID: 28879709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.
    Hiraoka S; Takashima S; Inokuchi T; Nakarai A; Takahara M; Harada K; Seki Y; Watanabe K; Kato J; Okada H
    Intest Res; 2019 Apr; 17(2):202-209. PubMed ID: 30541228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.